Vernacchio v. Secretary of Health and Human Services
Opinion
In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 08-504V (to be published)
*****************************
*
ROBERT VERNACCHIO and ERICA * VERNACCHIO, parents and natural guardians * of, L.V., a minor, * * Filed: April 10, 2015 Petitioners, *
*
v. *
*
SECRETARY OF HEALTH AND * HUMAN SERVICES, *
*
Respondent. *
*
*****************************
Robert Krakow, Law Office of Robert J. Krakow, P.C., New York, NY, for Petitioners.
Lynn Ricciardella, U.S. Dep’t of Justice, Washington, DC, for Respondent.
ORDER DENYING PETITIONERS’ MOTION FOR RECONSIDERATION 1
On October 25, 2002, Robert and Erica Vernacchio, the parents and natural guardians of L.V., a minor, filed the above-captioned action in the National Vaccine Injury Compensation Program (the “Program”). 2 Their subsequently-amended petition alleges that the influenza (“flu”) vaccine that L.V. received on December 8, 2006, caused L.V. to develop a neurodevelopmental disorder and other medical conditions and symptoms. Amended Pet. at 3, dated April 9, 2012 (ECF No. 27). The matter is currently scheduled for hearing beginning April 13, 2015.
1 Because this order contains a reasoned explanation for my action in this case, I will post this order on the United States Court of Federal Claims’ website, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, § 205, 116 Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2006)). As provided by 42 U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the posted order’s inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen (14) days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole order will be available to the public. Id.
2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3758, codified as amended, 42 U.S.C. §§ 300aa-10 through 34 (2006) [hereinafter “Vaccine Act” or “the Act”]. Individual section references hereafter will be to § 300aa of the Act.
On January 5, 2015, the Vernacchios filed a Motion for Judicial Estoppel. In it, they argued that Respondent should be precluded at trial from adopting a factual position in defending against the claim that is contrary to the position that Petitioners allege Respondent adopted in a different Vaccine Program case, Poling v. Sec’y of Health & Human Servs., No. 02-1466V, 2008 WL 1883059 (Fed. Cl. Spec. Mstr. Apr. 10, 2008) [hereinafter Poling]. Respondent conceded Poling and ultimately settled it.
After the matter was fully briefed, I issued an order denying Petitioners’ Motion for Judicial Estoppel on March 6, 2015 (ECF No. 124) (“Estoppel Order”). As my order sets forth, I denied the motion because I determined that the Vernacchios had not established any basis (whether through the application of collateral or judicial estoppel) for preventing Respondent from litigating causation issues and theories similar to those that were advanced in Poling, even if Respondent conceded liability in that case. By motion dated April 4, 2015 (ECF No. 136) (“Reconsideration Mot.”), Petitioners now request reconsideration of that order.
I. Legal Analysis of Reconsideration Motions
Here, the Vernacchios challenge an “order” issued in the case rather than a “decision”
involving a compensation determination. I find little direct guidance in the Vaccine Rules or case law from other Program petitions as to the standard of law to be applied to requests for reconsideration of a case order. Vaccine Rule 10(e), however, which governs motions for reconsideration of a special master’s decision, has some utility in addressing the merits of the Vernacchios’ motion. As that rule provides, “[e]ither party may file a motion for reconsideration of the special master’s decision within 21 days after the issuance of the decision . . . .” Vaccine Rule 10(e)(1). Special masters have the discretion to grant a motion for reconsideration if to do so would be in the “interest of justice.” Vaccine Rule 10(e)(3).
As noted by another special master, “there is a dearth of law interpreting Vaccine Rule 10(e)(3),” beyond the conclusion that, as the rule makes clear, it is within the special master’s discretion to decide what the “interest of justice” is in a given case. Krakow v. Sec’y of Health & Human Servs., No. 03-632V, 2010 WL 5572074, at *3 (Fed. Cl. Spec. Mstr. Jan. 10, 2011) (granting reconsideration of motion to dismiss case for failure to prosecute). Many decisions appear to assume that the standard for reconsideration is congruent with the “manifest injustice” standard utilized under Rule 59(a) of the Rules of the Court of Federal Claims 3, which has been defined to be unfairness that is “clearly apparent or obvious.” Amnex, Inc. v. United States, 52 Fed. Cl. 555, 557 (2002); see also Krakow, 2010 WL 5572074, at *3-*5 (citations omitted). At bottom, the Krakow order suggests that the “interest of justice” standard is more lenient, placing
3 RCFC 59(a) sets forth three possible bases for obtaining reconsideration of an order: (a) a change in controlling law; (b) the presence of previously unavailable evidence; or (c) manifest injustice. System Fuels, Inc. v. United States, 79 Fed. Cl. 182, 184 (2007).
importance on whether reconsideration would provide a Vaccine Act petitioner a full opportunity to prove their case. Id. at *5.
II. Analysis of Petitioners’ Motion
At the outset, I note that the eleventh-hour nature of the Vernacchios’ motion for reconsideration is troubling. Not only has the motion been filed within ten days of trial, but also it would be facially untimely if Rule 10(e) applied, since it was interposed twenty-nine days after my March 6, 2015, Order denying the first estoppel motion. Too much of the past several months leading to trial has been devoted to consideration of Petitioners’ estoppel arguments.
But even if I disregard its untimely character, I find that the reconsideration motion is substantively unpersuasive, as it relies not on new factual or legal developments but instead merely recasts arguments that were previously made (or could have been made).
As with their original estoppel motion, Petitioners’ motion for reconsideration relies heavily on the fact that this case originally fell within the Omnibus Autism Proceeding (“OAP”), and thus overlapped with Poling for a period of time (along with thousands of other cases). Now, however, the Vernacchios maintain that there is a meaningful distinction between the “concession” of a legal or factual issue in a case and the act of settling a case in its entirety. Thus, the Vernacchios assert that because in the Poling case the Respondent (in her Rule 4(c) report, filed prior to that case’s resolution) unilaterally conceded the evidentiary sufficiency of a medical theory that Petitioners wish to invoke in the present case (namely, that a vaccine can aggravate an underlying mitochondrial disorder and cause a regressive encephalopathy), that concession should be given estoppel effect herein despite the fact that Respondent subsequently settled the damages issues. Reconsideration Mot. at 3-4.
Free access — add to your briefcase to read the full text and ask questions with AI
Vernacchio v. Secretary of Health and Human Services (Vernacchio v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.